MetaVia Inc.

Nasdaq:MTVA

Pharmaceutical Preparations·CAMBRIDGE, MA

CEO

Kim Hyung Heon

CFO

Woodworth Marshall H

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/6/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/20/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
1/5/26	Q4 FY2026	→
11/6/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/14/25	Q2 FY2025	→
3/20/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
↓

News (8-K)

68 shown

Filed	Type	Description
1/27/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/16/26	Agreement	Entry into a Material Definitive Agreement	→
1/5/26	Reg FD	Regulation FD Disclosure	→
12/19/25	Other	Other Events	→
12/2/25	Reg FD	Material Modification to Rights of Security Holders	→
11/26/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/16/26	424B4	424B4	→
1/15/26	S-1MEF	FORM S-1MEF	→
1/12/26	S-1/A	S-1/A	→
1/6/26	FWP	FWP	→
1/5/26	S-1	S-1	→
11/6/25	424B5	424B5	→
↓

Filing History(589 filings)

TypeDateAccessionPeriodSize

Jan 27, 2026

0001104659-26-006978OWNERSHIP DOCUMENT

Jan 23, 2026

5.3 KB

8-K

Jan 27, 2026

0001104659-26-0069768-K

Jan 23, 2026

215.8 KB

Jan 27, 2026

0001104659-26-006975OWNERSHIP DOCUMENT

Jan 23, 2026

13.9 KB

8-K

Jan 16, 2026

0001104659-26-004532FORM 8-K

Jan 15, 2026

1.2 MB

424B4

Jan 16, 2026

0001104659-26-004337424B4

—

4.1 MB

EFFECT

Jan 15, 2026

9999999995-26-000181

—

1.9 KB

S-1MEF

Jan 15, 2026

0001104659-26-003908FORM S-1MEF

—

263.3 KB

S-1/A

Jan 12, 2026

0001104659-26-002930S-1/A

—

5.1 MB

FWP

Jan 6, 2026

0001104659-26-000793FWP

—

8.7 MB

8-K

Jan 5, 2026

0001104659-26-000736FORM 8-K

Jan 5, 2026

232.1 KB

S-1

Jan 5, 2026

0001104659-26-000695S-1

—

18.6 MB

8-K

Jan 5, 2026

0001104659-26-000432FORM 8-K

Jan 5, 2026

238.3 KB

8-K

Dec 19, 2025

0001104659-25-123099FORM 8-K

Dec 19, 2025

230.8 KB

8-K

Dec 2, 2025

0001104659-25-1175408-K

Dec 2, 2025

260.5 KB

8-K

Nov 26, 2025

0001104659-25-1164568-K

Nov 26, 2025

177.1 KB

8-K

Nov 7, 2025

0001104659-25-1081798-K

Nov 7, 2025

245.0 KB

424B5

Nov 6, 2025

0001104659-25-107825424B5

—

567.5 KB

8-K

Nov 6, 2025

0001104659-25-1077908-K

Nov 6, 2025

5.7 MB

10-Q

Nov 6, 2025

0001104659-25-10772610-Q

Sep 30, 2025

6.1 MB

8-K

Nov 6, 2025

0001104659-25-1074478-K

Nov 6, 2025

407.0 KB

DRS

Oct 17, 2025

0001104659-25-100342

—

974.2 KB

SCHEDULE 13G/A

Aug 14, 2025

0001172661-25-003591

—

9.2 KB

Aug 13, 2025

0001104659-25-077612OWNERSHIP DOCUMENT

Aug 12, 2025

13.7 KB

8-K

Aug 7, 2025

0001558370-25-0107878-K

Aug 7, 2025

5.7 MB

10-Q

Aug 7, 2025

0001558370-25-01075910-Q

Jun 30, 2025

5.7 MB

25 filings shown

Filed	Form	Description
6/10/25	DEF 14A	DEF 14A	→
5/27/25	PRE 14A	PRE 14A	→
8/21/24	DEF 14A	DEF 14A	→
8/7/24	PRE 14A	PRE 14A	→
4/30/24	DEF 14A	DEF 14A	→
5/26/23	DEF 14A	DEF 14A	→
↓

MetaVia Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(589 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/27/26	4	OWNERSHIP DOCUMENT	→
1/27/26	4	OWNERSHIP DOCUMENT	→
8/13/25	4	OWNERSHIP DOCUMENT	→
7/1/25	4	OWNERSHIP DOCUMENT	→
7/1/25	4	OWNERSHIP DOCUMENT	→
7/1/25	4	OWNERSHIP DOCUMENT	→
↓